Heineken: UBS remains positive ahead of H1 results

(CercleFinance.com) - UBS maintains its 'buy' recommendation on Heineken shares, as well as its target price of E105, which gives the Dutch brewer's stock 14% upside potential, ahead of its H1 results.


The broker sees 'upside risk' on Q2 organic sales growth, expecting +6.4%, vs. a consensus of +5.6%, and more significantly on H1 EBIT growth, forecasting +20%, vs. a consensus of +10.4%.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as decision-making aids for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.